<![CDATA[Introduction: Recurrent nasopharyngeal carcinoma is a tumor that relapse after remission is completed whose treatment is still a challenge in the medical field because it has a set of medical properties a truly unique pathway. It is very important to understand the recurrence of nasopharyngeal carcinoma including the importance of improving individual management guidelines as well as a complete evaluation of the quality of life of patients. Objective: Statements of purpose of the study. Methods: The method carried out in this study is retrospective descriptive research retrieval from patient’s medical record with recurrent nasopharyngeal carcinoma at Oncology Head Neck Surgery of ORL-HNS outpatient clinic, Hasan Sadikin General Hospital Bandung from 2017 to 2019. Results: Between 2017-2019 period, there were 1.727 outpatient NPC with recurrent NPC were 135 patients (7.8%). Most of them were treated by chemotherapy (45%) followed by combination therapy (30%), and radiotherapy (25%). Conclusion: Most recurrent NCP patients in this study were treated by chemotherapy (45%). Treatment techniques should be highly individualized and depend on the site and extent of recurrence, previous treatment, and the availability of equipment and expertise.]]>
Copyrights © 2020
